Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

Gilead Sciences Inc (GILD)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mick Member Profile
Member Level 
Followed By 2,743
Posts 884,396
Boards Moderated 329
Alias Born 09/04/00
160x600 placeholder
Gilead Sciences to Present at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 Business Wire - 11/23/2020 7:00:00 PM
Pfizer, Gilead, Ross: What to Watch When the Stock Market Opens Today Dow Jones News - 11/20/2020 9:31:00 AM
Pfizer, Gilead, Ross: What to Watch When the Stock Market Opens Today Dow Jones News - 11/20/2020 8:30:00 AM
Pfizer, Gilead, Ross: What to Watch When the Stock Market Opens Today Dow Jones News - 11/20/2020 7:32:00 AM
WHO Recommends Against Use of Gilead Covid-19 Drug Remdesivir -- Update Dow Jones News - 11/19/2020 7:54:00 PM
WHO Recommends Against Use of Gilead Covid-19 Drug Remdesivir Dow Jones News - 11/19/2020 7:40:00 PM
Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Stud... Business Wire - 11/18/2020 8:35:00 AM
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH Business Wire - 11/15/2020 5:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 5:51:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 5:45:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 5:35:15 PM
Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 Business Wire - 11/5/2020 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2020 6:05:34 AM
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Ulcerative Colitis Business Wire - 11/2/2020 4:01:00 PM
Gilead Quarterly Revenue Rises on Remdesivir Sales -- Update Dow Jones News - 10/28/2020 7:33:00 PM
Gilead Quarterly Revenue Rises on Remdesivir Sales Dow Jones News - 10/28/2020 5:40:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2020 4:11:05 PM
Gilead Sciences Announces Fourth Quarter 2020 Dividend Business Wire - 10/28/2020 4:02:00 PM
Gilead Sciences Announces Third Quarter 2020 Financial Results Business Wire - 10/28/2020 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/26/2020 7:13:19 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/26/2020 7:09:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/23/2020 5:13:26 PM
Gilead Sciences Completes Acquisition of Immunomedics, Inc. Business Wire - 10/23/2020 9:15:00 AM
Covid-19 Drug Remdesivir Fully Approved by FDA Dow Jones News - 10/22/2020 6:39:00 PM
FDA Approves Gilead Sciences' Remdesivir Treatment for Covid-19 Dow Jones News - 10/22/2020 5:01:00 PM
mick Member Level  Thursday, 05/28/20 02:16:54 AM
Re: mick post# 3800
Post # of 4732 
Gilead Sciences Inc (GILD)
74.9 ? 1.72 (2.35%)
Volume: 11,752,332 @05/27/20 7:59:18 PM EDT
Bid Ask Day's Range
70.3 79.0 72.38 - 74.98
GILD Detailed Quote

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences